FDA-Drug2026-09-09Class IIPROCESSING DEFECT
Teva trazodone 50 mg tablets recalled for foreign tablets in bottles
What this means
Teva Pharmaceuticals discovered that some bottles of trazodone 50 mg tablets contain foreign tablets or capsules mixed in with the correct medication. The issue affects one lot (1394026) with an expiration date of February 2028. No injuries have been reported.
- Check your trazodone bottle against lot number 1394026 and expiration date 02/2028.
- If your bottle matches, do not use it and contact your pharmacy or doctor.
- Return the affected bottle to your pharmacy for a replacement.
The agency's original wording
Hazard
Presence of Foreign Tablets/Capsules
Intended for
Adults
Illnesses reported
None reported
Sold states
U.S. Nationwide
Affected count
175,392 bottles
Manufactured in
400 Interpace Pkwy Bldg A, N/A, Parsippany, NJ, United States
Products
traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o, Zagreb, Croatia, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 50111-560-01
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0834-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.